# Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA

> **NCT06948552** · PHASE2 · RECRUITING · sponsor: **Henry Ford Health System** · enrollment: 10 (estimated)

## Conditions studied

- Upper Tract Urothelial Carcinoma

## Interventions

- **DRUG:** 5-Aminolevulinic acid Hydrochloride (Gliolan®)

## Key facts

- **NCT ID:** NCT06948552
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-12
- **Final completion:** 2028-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06948552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06948552, "Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06948552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*